MedTrace Logo

Clinical Trial of Molecular Biomarkers in Women With Uterine Cervix Cancer

NCT05462951 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 19

Last updated 2025-11-28

No results posted yet for this study

Summary

This is a phase 0 clinical trial of molecular biomarkers in women with uterine cervix cancer. Women receive standard-of-care radiochemotherapy followed by brachytherapy. Blood samples are obtained to detect circulating levels of deoxyribonucleotides, human papillomavirus DNA, and circulating tumor cells.

Conditions

  • Uterine Cervix Cancer

Interventions

RADIATION

Standard

Radiation then brachytherapy

Sponsors & Collaborators

  • UK Radiopharma Alliance

    collaborator UNKNOWN

  • Denise Fabian

    lead OTHER

Principal Investigators

  • Denise Fabian, MD · University of Kentucky

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-03
Primary Completion
2026-06-01
Completion
2026-06-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05462951 on ClinicalTrials.gov